Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort.

Juvenile scleroderma diffuse cutaneous subset juvenile systemic sclerosis limited cutaneous subset organ involvement patient-related outcomes

Journal

Journal of scleroderma and related disorders
ISSN: 2397-1991
Titre abrégé: J Scleroderma Relat Disord
Pays: England
ID NLM: 101685427

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 16 03 2018
accepted: 01 07 2018
entrez: 6 4 2022
pubmed: 1 2 2019
medline: 1 2 2019
Statut: ppublish

Résumé

Juvenile systemic sclerosis is an orphan disease. Currently, the majority of juvenile systemic sclerosis cohort studies are retrospective in design without standardized assessment. This study was conducted prospectively to investigate the difference in manifestations of limited cutaneous juvenile systemic sclerosis and diffuse cutaneous juvenile systemic sclerosis subtypes. An additional aim was to compare these data to other juvenile systemic sclerosis cohorts and a large adult systemic sclerosis cohort. Patients fulfilling the Paediatric Rheumatology European Society juvenile systemic sclerosis classification criteria were included. Clinical characteristics and patient-related outcomes were assessed. In all, 88 patients with a mean disease duration of 3.5 years were enrolled, 72.5% with diffuse cutaneous juvenile systemic sclerosis with a mean modified Rodnan Skin score of 18 and 27.5% with limited cutaneous juvenile systemic sclerosis with mean modified Rodnan Skin score of 9. The mean age at the onset of Raynaud's and first non-Raynaud's symptoms was similar in both groups, approximately 9 and 10.5 years. Active digital tip ulcerations were present in 29% diffuse cutaneous juvenile systemic sclerosis and none in the limited cutaneous juvenile systemic sclerosis subjects (p = 0.005). Of those with cardiopulmonary testing, 3% of diffuse cutaneous juvenile systemic sclerosis and 23% of limited cutaneous juvenile systemic sclerosis group had cardiac involvement (p = 0.015), and 41% diffuse cutaneous juvenile systemic sclerosis and 22% of the limited cutaneous juvenile systemic sclerosis group had pulmonary involvement (p = 0.009). Physician global disease damage assessment was higher in the diffuse cutaneous juvenile systemic sclerosis group compared to the limited cutaneous juvenile systemic sclerosis group: 35 and 15 (p = 0.021). The majority of this international juvenile systemic sclerosis cohort had diffuse cutaneous juvenile systemic sclerosis (72.5%) with more frequent vascular and pulmonary involvement compared to the limited cutaneous group, who had increased cardiac involvement. Our cohort reflects prior findings of published juvenile systemic sclerosis cohorts and emphasizes a difference in the presentation compared to adult-onset systemic sclerosis.

Identifiants

pubmed: 35382144
doi: 10.1177/2397198318790494
pii: 10.1177_2397198318790494
pmc: PMC8922583
doi:

Types de publication

Journal Article

Langues

eng

Pagination

49-61

Informations de copyright

© The Author(s) 2018.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Références

J Scleroderma Relat Disord. 2016 May-Aug;1(2):177-240
pubmed: 29242839
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
J Dermatol. 2007 Sep;34(9):658-61
pubmed: 17727371
Arthritis Care Res (Hoboken). 2014 Mar;66(3):404-10
pubmed: 23983017
Clin Rheumatol. 2007 Aug;26(8):1259-62
pubmed: 17180299
Rheumatology (Oxford). 2000 May;39(5):556-9
pubmed: 10852989
Ann Rheum Dis. 2016 Sep;75(9):1736-40
pubmed: 27353738
J Rheumatol. 2014 Jun;41(6):1040-8
pubmed: 24833760
J Rheumatol. 2006 May;33(5):1004-13
pubmed: 16583463
Arthritis Rheum. 2006 Dec;54(12):3971-8
pubmed: 17133611
Arthritis Care Res (Hoboken). 2010 Feb;62(2):213-8
pubmed: 20191520
Ann Rheum Dis. 2012 Aug;71(8):1355-60
pubmed: 22615460
Rheumatology (Oxford). 2011 Jan;50(1):60-8
pubmed: 21148153
Ann Rheum Dis. 2016 Jan;75(1):163-9
pubmed: 25342760
Pediatr Rheumatol Online J. 2007 May 01;5:6
pubmed: 17550632
Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii32-5
pubmed: 19487221
Lupus. 2018 Mar;27(3):494-500
pubmed: 29251171
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14
pubmed: 22556030
Arthritis Rheum. 2007 Mar 15;57(2):203-12
pubmed: 17330294
Pediatr Rheumatol Online J. 2017 Apr 17;15(1):30
pubmed: 28416023
J Rheumatol. 2002 Aug;29(8):1767-73
pubmed: 12180742
J Scleroderma Relat Disord. 2017 Jan-Apr;2(1):11-18
pubmed: 28516167
Ann Rheum Dis. 2011 Oct;70(10):1788-92
pubmed: 21784727
Rheumatology (Oxford). 2016 May;55(5):883-90
pubmed: 26843483

Auteurs

Ivan Foeldvari (I)

Hamburg Centre for Pediatric and Adolescent Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, Germany.

Jens Klotsche (J)

German Rheumatism Research Center, Berlin, Germany.

Kathryn S Torok (KS)

Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.

Ozgur Kasapcopur (O)

Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.

Amra Adrovic (A)

Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.

Valda Stanevicha (V)

University Children's Hospital, Riga, Latvia.

Maria Teresa Terreri (MT)

Universidade Federal de São Paulo, Sao Paulo, Brazil.

Ekaterina Alexeeva (E)

Scientific Center of Children's Health, Moskva, Russia.

Maria Katsicas (M)

Hospital de Pediatria, Buenos Aires, Argentine.

Rolando Cimaz (R)

Meyer Children's Hospital, Florence, Italy.

Mikhail Kostik (M)

Federal State Autonomous Institution "National Medical Research Center of Children's Health" of the Ministry of Health of the Russian Federation, Moscow, Russia.

Thomas Lehman (T)

Hospital for Special Surgery, New York, NY, USA.

Walter-Alberto Sifuentes-Giraldo (WA)

University Hospital Ramón y Cajal, Madrid, Spain.

Vanessa Smith (V)

Department of Internal Medicine, Ghent University, Ghent, Belgium.

Flavio Sztajnbok (F)

Universidade do Estado, Rio de Janeiro, Brazil.

Tadej Avcin (T)

University Children's Hospital Ljubljana, Ljubljana, Slovenia.

Maria Jose Santos (M)

Serviço de Reumatologia, Hospital Garcia de Orta, Almada, Portugal.

Monika Moll (M)

Pediatric Rheumatology, University Tübingen, Tübingen, Germany.

Dana Nemcova (D)

Department of Pediatrics and Adolescent Medicine, University Childrens Hospital, Prague, Czech Republic.

Cristina Battagliotti (C)

Hospital de Niños Dr. Orlando Alassia, Santa Fee, Argentine.

Despina Eleftheriou (D)

Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Mahesh Janarthanan (M)

Pediatric Rheumatology, Sri Ramachandra University, Chennai, India.

Tilmann Kallinich (T)

Division of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany.

Jordi Anton (J)

Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.

Kirsten Minden (K)

German Rheumatism Research Center, Berlin, Germany.
Division of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany.

Susan Nielsen (S)

Rigshospitalet, Copenhagen, Denmark.

Yosef Uziel (Y)

Meir Medical Center, Tel Aviv University, Kfar Saba, Israel.

Nicola Helmus (N)

Hamburg Centre for Pediatric and Adolescent Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, Germany.

Classifications MeSH